393 related articles for article (PubMed ID: 12543779)
1. BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma.
French CA; Miyoshi I; Kubonishi I; Grier HE; Perez-Atayde AR; Fletcher JA
Cancer Res; 2003 Jan; 63(2):304-7. PubMed ID: 12543779
[TBL] [Abstract][Full Text] [Related]
2.
Zheng D; Elnegiry AA; Luo C; Bendahou MA; Xie L; Bell D; Takahashi Y; Hanna E; Mias GI; Tsoi MF; Gu B
Life Sci Alliance; 2024 Jul; 7(7):. PubMed ID: 38724194
[TBL] [Abstract][Full Text] [Related]
3. Primary cutaneous NUT carcinoma with BRD4::NUTM1 fusion.
Shah A; Box A; Brenn T; Flaman A
J Cutan Pathol; 2024 Jun; 51(6):424-429. PubMed ID: 38481096
[TBL] [Abstract][Full Text] [Related]
4. Clinical Response of Carcinomas Harboring the BRD4-NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015/MK-8628.
Stathis A; Zucca E; Bekradda M; Gomez-Roca C; Delord JP; de La Motte Rouge T; Uro-Coste E; de Braud F; Pelosi G; French CA
Cancer Discov; 2016 May; 6(5):492-500. PubMed ID: 26976114
[TBL] [Abstract][Full Text] [Related]
5. The BRD4-NUT Fusion Alone Drives Malignant Transformation of NUT Carcinoma.
Durall RT; Huang J; Wojenski L; Huang Y; Gokhale PC; Leeper BA; Nash JO; Ballester PL; Davidson S; Shlien A; Sotirakis E; Bertaux F; Dubus V; Luo J; Wu CJ; Keskin DB; Eagen KP; Shapiro GI; French CA
Cancer Res; 2023 Dec; 83(23):3846-3860. PubMed ID: 37819236
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of NUT midline carcinoma by epigenomic reprogramming.
Schwartz BE; Hofer MD; Lemieux ME; Bauer DE; Cameron MJ; West NH; Agoston ES; Reynoird N; Khochbin S; Ince TA; Christie A; Janeway KA; Vargas SO; Perez-Atayde AR; Aster JC; Sallan SE; Kung AL; Bradner JE; French CA
Cancer Res; 2011 Apr; 71(7):2686-96. PubMed ID: 21447744
[TBL] [Abstract][Full Text] [Related]
7. Structural mechanism of BRD4-NUT and p300 bipartite interaction in propagating aberrant gene transcription in chromatin in NUT carcinoma.
Yu D; Liang Y; Kim C; Jaganathan A; Ji D; Han X; Yang X; Jia Y; Gu R; Wang C; Zhang Q; Cheung KL; Zhou MM; Zeng L
Nat Commun; 2023 Jan; 14(1):378. PubMed ID: 36690674
[TBL] [Abstract][Full Text] [Related]
8. Translocations and Gene Fusions in Sinonasal Malignancies.
Larkin R; Hermsen MA; London NR
Curr Oncol Rep; 2023 Apr; 25(4):269-278. PubMed ID: 36753024
[TBL] [Abstract][Full Text] [Related]
9. The expanding universe of NUTM1 fusions in pediatric cancer.
Charlab R; Racz R
Clin Transl Sci; 2023 Aug; 16(8):1331-1339. PubMed ID: 37082775
[TBL] [Abstract][Full Text] [Related]
10. Cell state-dependent chromatin targeting in NUT carcinoma.
Alekseyenko AA; Zee BM; Dhoondia Z; Kang H; Makofske JL; Kuroda MI
Genetics; 2023 Jul; 224(3):. PubMed ID: 37119804
[TBL] [Abstract][Full Text] [Related]
11. High-Grade Spindle Cell Sarcoma of the Scalp With an MGA::NUTM1 Gene Fusion in a Pediatric Patient.
Arellano Zameza P; Karklins SP; Pena J; Bowers NL; Samman A; Ahn C; Sangueza OP
Am J Dermatopathol; 2024 Feb; 46(2):101-103. PubMed ID: 38055974
[TBL] [Abstract][Full Text] [Related]
12. ARV-825 Showed Antitumor Activity against BRD4-NUT Fusion Protein by Targeting the BRD4.
Yang L; Jing Y; Xia X; Yin X
J Oncol; 2023; 2023():9904143. PubMed ID: 38130463
[TBL] [Abstract][Full Text] [Related]
13. Metabolic and Epigenetic Reprogramming in a Case of Nuclear Protein in Testis (NUT) Carcinoma of the Retroperitoneum.
Serizawa M; Serizawa K; Masui K; Toguchi M; Murakami K; Yamamoto T; Nagashima Y; Takagi T; Kurata A
Cureus; 2024 Jan; 16(1):e52814. PubMed ID: 38389647
[TBL] [Abstract][Full Text] [Related]
14. NUTM1 -rearranged Carcinoma of the Thyroid : A Distinct Subset of NUT Carcinoma Characterized by Frequent NSD3 - NUTM1 Fusions.
Barletta JA; Gilday SD; Afkhami M; Bell D; Bocklage T; Boisselier P; Chau NG; Cipriani NA; Costes-Martineau V; Ghossein RA; Hertzler HJ; Kramer AM; Limaye S; Lopez CA; Ng TL; Weissferdt A; Xu B; Zhang S; French CA
Am J Surg Pathol; 2022 Dec; 46(12):1706-1715. PubMed ID: 36040068
[TBL] [Abstract][Full Text] [Related]
15. Clinical management of NUT carcinoma (NC) in Germany: Analysis of survival, therapy response, tumor markers and tumor genome sequencing in 35 adult patients.
Kloker LD; Sidiras M; Flaadt T; Brecht IB; Deinzer CKW; Groß T; Benzler K; Zender L; Lauer UM
Lung Cancer; 2024 Mar; 189():107496. PubMed ID: 38301600
[TBL] [Abstract][Full Text] [Related]
16. An Overview of Molecular Mechanism, Clinicopathological Factors, and Treatment in NUT Carcinoma.
Huang QW; He LJ; Zheng S; Liu T; Peng BN
Biomed Res Int; 2019; 2019():1018439. PubMed ID: 31815119
[TBL] [Abstract][Full Text] [Related]
17. Molecular and clinicopathologic characteristics of CNS embryonal tumors with BRD4::LEUTX fusion.
Andreiuolo F; Ferrone CK; Rajan S; Perry A; Guney E; Cham E; Giannini C; Toland A; Willard N; de Souza AS; Dazelle K; Chung HJ; Singh O; Conway K; Coley N; Dampier C; Abdullaev Z; Pratt D; Cimino PJ; Quezado M; Aldape K
Acta Neuropathol Commun; 2024 Mar; 12(1):42. PubMed ID: 38500181
[TBL] [Abstract][Full Text] [Related]
18. Exceptional Response to Bromodomain and Extraterminal Domain Inhibitor Therapy With BMS-986158 in
Cheng ML; Huang Y; Luong N; LoPiccolo J; Nishino M; Sholl LM; Chirieac LR; Santucci AD; Rabin MS; Jänne PA; Coker S; Diamond JR; Hilton J; Shapiro GI; French CA
JCO Precis Oncol; 2023 Jun; 7():e2200633. PubMed ID: 37384867
[No Abstract] [Full Text] [Related]
19. Placental metastasis from maternal NUT carcinoma: diagnostic pitfalls and challenges.
Lai JK; Panasci L; Patey NG; Wang H
BMJ Case Rep; 2024 Apr; 17(4):. PubMed ID: 38569728
[TBL] [Abstract][Full Text] [Related]
20. An Anatomical Site and Genetic-Based Prognostic Model for Patients With Nuclear Protein in Testis (NUT) Midline Carcinoma: Analysis of 124 Patients.
Chau NG; Ma C; Danga K; Al-Sayegh H; Nardi V; Barrette R; Lathan CS; DuBois SG; Haddad RI; Shapiro GI; Sallan SE; Dhar A; Nelson JJ; French CA
JNCI Cancer Spectr; 2020 Apr; 4(2):pkz094. PubMed ID: 32328562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
